Hypopharyngeal Cancer Treatment; Chemotherapy, Surgery, and Radiation Therapy

 

Hypopharyngeal cancer treatment involves chemotherapy, surgery, and radiation therapy. One or a combination of these therapies can be used for hypopharyngeal cancer treatment. Radiation therapy and Surgery are the most common treatments. Hypopharyngeal cancer is one of the most common forms of cancer that affects the throat. It can be difficult to diagnose initially, especially if it does not have noticeable symptoms, such as inflammation of the lymph nodes in and around the throat, but if there are any symptoms, they should be diagnosed early.

Hypopharyngeal cancer is very rare, however, is difficult to diagnose in its earliest stages and has one of the highest mortality rates of any head and neck cancer. It is mostly diagnosed in men who smoke tobacco and consume excessive alcohol. When doctors plan hypopharyngeal cancer treatment, they consider how treatment can affect a person's quality of life, including how the person breathes, eats, talks, looks, and feels because hypopharyngeal cancer treatment can significantly affect these functions, treatment must therefore be made with caution.

This is important because this form of cancer is often very difficult to detect due to the fact that it does not have a major external symptom or sign. A patient may have no outward symptom at all, or only one or two very intense symptoms. Most people who suffer from some form of cancer, whether it is just lumps or other forms, often have no prior warning before their cancer becomes active. This is why early diagnosis and treatment are important for a person's recovery from this disease.

However, hypopharyngeal cancer treatment depends on several factors, such as the patient’s preferences, the patient’s overall health, the type and stage of cancer, and possible side effects. Worldwide, head and neck cancer accounts for more than 900,000 cases and 370,000 deaths every year. Moreover, head and neck cancer, in Japan alone, accounts for more than 39,000 cases and 10,000 deaths annually. With the increasing prevalence of cancer, the demand for hypopharyngeal cancer treatment is also increasing at a rapid pace.